Natixis Advisors, L.P. Dr Reddys Laboratories LTD Transaction History
Natixis Advisors, L.P.
- $46 Billion
- Q2 2024
A detailed history of Natixis Advisors, L.P. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Natixis Advisors, L.P. holds 10,202 shares of RDY stock, worth $813,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,202Holding current value
$813,201% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding RDY
# of Institutions
233Shares Held
24MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$165 Million0.34% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$164 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$162 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2MShares$159 Million0.27% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$144 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $13.2B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...